... and other developed regions between 2010 and 2030. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, ...
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130409006456&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130409006456&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment